Merrimack Reports Fourth Quarter and Full-Year 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
Merrimack Pharma (MACK) Misses Q4 EPS by 4c
March 1, 2017 7:10 AM ESTMerrimack Pharma (NASDAQ: MACK) reported Q4 EPS of ($0.25), $0.04 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $61.24 million versus the consensus estimate of $50.44 million.
2017 Financial Outlook
Upon the closing of the asset sale, Merrimack will receive a $575.0... More
